| 摘要 |
<p>1,236,474. 3 - Oxo - A,19 - bisnor - B - homosteroid - 5(10) - enes. CIBA - GEIGY A.G. 9 Dec., 1968 [18 Dec., 1967], No. 58414/68. Headings C2C and C2U. Title compounds which do not contain a 6-oxo group are novel and are prepared by reaction with a strong base of 3,10-dioxo-S,10- seco-19-nor-steroids or tautomers thereof. In the products a ketalized oxo group may be converted to a free oxo group, an esterified or etherified hydroxy group may be hydrolysed to a free hydroxy group, a 17-oxo group may be reduced to a 17#-hydroxy group with or without a 17α-aliphatic hydrocarbon radical, and a free 17#-hydroxy group may be esterified or etherified. 3,10,17 - Trioxo - 5,10 - seco - estrane is prepared by hydrolysis of 3,3-ethylenedioxy- 10,17 - dioxo - 5,10 - seco - estrane, prepared in turn by catalytic hydrogenation of 3,3-ethylenedioxy - 10,17 - dioxo - 5,10 - seco - estr - 5 - yne. The corresponding 17#-ols are prepared similarly, the starting material being prepared by reduction of the last-named compound. 3,10- Dioxo - 17# - hydroxy - 17α- methyl - 5,10 - secoestrane is prepared from 3,3,17,17-bisethylenedioxy - 6# - acetoxy - estr - 5(10) - ene by hydrolysis of the 17-ketal, reaction of the ketone with methyl magnesium bromide, epoxi. dation of the #<SP>5(10)</SP>-double bond, oxidation of the 6#-OH group, reaction with tosyl hydrazine, hydrogenation of the triple bond in the resulting seco-steroid and hydrolysis of the 3-ketal. The title compounds are stated to possess androgenic, anabolic and antigonadrotropic activity, and they may be made up into pharmaceutical compositions with suitable carriers.</p> |
